Stability of HIV-1 RNA in blood during specimen handling and storage prior to amplification by NASBA-QT

被引:35
作者
Bruisten, SM
Oudshoorn, P
vanSwieten, P
BoeserNunnink, B
vanAarle, P
Tondreau, SP
Cuypers, HTM
机构
[1] ORGANON TEKN,RES & DEV GRP,NL-5281 RM BOXTEL,NETHERLANDS
[2] ADV BIOSCI LABS,PROC VALIDAT GRP,KENSINGTON,MD
关键词
HIV-1; RNA; stability; storage conditions; NASBA-QT;
D O I
10.1016/S0166-0934(97)00097-9
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The influence of different storage temperatures and anticoagulation conditions on the HIV-1 RNA load as measured by NASBA-QT was examined. Blood specimens from 14 HIV-1 infected individuals were processed within 2 h after collection. The HIV-1 RNA load remained stable for at least 6 months when samples were frozen directly at -70 degrees C in lysis buffer. This lysis buffer fully inactivated the virus. When whole EDTA blood was stored, the HIV-1 RNA load was stable for 72 h at 25 degrees C, but it declined within 24 h at 4 degrees C. The HIV-1 RNA load in whole heparinized blood declined significantly after 24 h at both 4 and 25 degrees C. It was slightly lower (average of 0.18 log ml(-1)) than in whole EDTA blood. At 4 degrees C, the HIV-RNA load in serum and EDTA-plasma stored with lysis buffer did not decline up to 14 days. At + 30 degrees C, however, the load declined significantly after 2 days. Of clinical significance, the mean load in EDTA plasma was 0.5 log ml(-1) higher than in serum. This difference was patient dependent (range 0.1-0.7 log ml(-1)). We thus recommend, for quantifying HIV-1 RNA by NASBA, to use preferably EDTA blood which is kept at room temperature until plasma separation. When using heparinized blood, the plasma should be stored frozen within 8 h. (C) 1997 Elsevier Science B.V.
引用
收藏
页码:199 / 207
页数:9
相关论文
共 25 条
[1]  
*ACTG, 1996, NEW ENGL J MED, V335, P1091
[2]  
*BELG AIDS REF LAB, 1995, J VIROL METHODS, V51, P305
[3]  
BEUTLER E, 1990, BIOTECHNIQUES, V9, P166
[4]   RAPID AND SIMPLE METHOD FOR PURIFICATION OF NUCLEIC-ACIDS [J].
BOOM, R ;
SOL, CJA ;
SALIMANS, MMM ;
JANSEN, CL ;
WERTHEIMVANDILLEN, PME ;
VANDERNOORDAA, J .
JOURNAL OF CLINICAL MICROBIOLOGY, 1990, 28 (03) :495-503
[5]   Prospective longitudinal analysis of viral load and surrogate markers in relation to clinical progression in HIV type 1-infected persons [J].
Bruisten, SM ;
Frissen, PHJ ;
VanSwieten, P ;
Harrigan, PR ;
Kinghorn, I ;
Larder, B ;
Weigel, HM ;
DeVries, E ;
Regez, RM ;
Henrichs, JH ;
Koot, M ;
Huisman, JG .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1997, 13 (04) :327-335
[6]   IMPACT OF SPECIMEN HANDLING AND STORAGE ON DETECTION OF HEPATITIS-C VIRUS-RNA [J].
BUSCH, MP ;
WILBER, JC ;
JOHNSON, P ;
TOBLER, L ;
EVANS, CS .
TRANSFUSION, 1992, 32 (05) :420-425
[7]   STORAGE-CONDITIONS OF BLOOD-SAMPLES AND PRIMER SELECTION AFFECT THE YIELD OF CDNA POLYMERASE CHAIN-REACTION PRODUCTS OF HEPATITIS-C VIRUS [J].
CUYPERS, HTM ;
BRESTERS, D ;
WINKEL, IN ;
REESINK, HW ;
WEINER, AJ ;
HOUGHTON, M ;
VANDERPOEL, CL ;
LESLIE, PN .
JOURNAL OF CLINICAL MICROBIOLOGY, 1992, 30 (12) :3220-3224
[8]   INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS GENE AMPLIFICATION BY HEPARIN [J].
HOLODNIY, M ;
KIM, S ;
KATZENSTEIN, D ;
KONRAD, M ;
GROVES, E ;
MERIGAN, TC .
JOURNAL OF CLINICAL MICROBIOLOGY, 1991, 29 (04) :676-679
[9]   COMPARATIVE STABILITIES OF QUANTITATIVE HUMAN-IMMUNODEFICIENCY-VIRUS RNA IN PLASMA FROM SAMPLES COLLECTED IN VACUTAINER CPT, VACUTAINER PPT, AND STANDARD VACUTAINER TUBES [J].
HOLODNIY, M ;
MOLE, L ;
YENLIEBERMAN, B ;
MARGOLIS, D ;
STARKEY, C ;
CARROLL, R ;
SPAHLINGER, T ;
TODD, J ;
JACKSON, JB .
JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (06) :1562-1566
[10]   DETECTION AND QUANTIFICATION OF HUMAN-IMMUNODEFICIENCY-VIRUS RNA IN PATIENT SERUM BY USE OF THE POLYMERASE CHAIN-REACTION [J].
HOLODNIY, M ;
KATZENSTEIN, DA ;
SENGUPTA, S ;
WANG, AM ;
CASIPIT, C ;
SCHWARTZ, DH ;
KONRAD, M ;
GROVES, E ;
MERIGAN, TC .
JOURNAL OF INFECTIOUS DISEASES, 1991, 163 (04) :862-866